School of Stomatology, Zhejiang Provincial Clinical Research Center for Oral Diseases, Stomatology HospitalZhejiang University School of MedicineKey Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University, Hangzhou, 310006, People's Republic of China.
Hangzhou 6D Dental Technologies Co., Ltd, Hangzhou, 310001, People's Republic of China.
Clin Oral Investig. 2022 Oct;26(10):6347-6359. doi: 10.1007/s00784-022-04590-y. Epub 2022 Jul 8.
This study aims to study the accuracy of cone beam computed tomography (CBCT) for measuring peri-implant bone thickness in living patients via a novel visualization method (NVM).
The validity of the NVM was verified ex vivo by measuring the same peri-implant bone thicknesses in bovine ribs by using raw postoperative CBCT (clinical measurement, CM), the visualized fused images obtained using the NVM (visualized fused measurement, VF), and hard tissue sections (gold standard measurement, GS). The NVM was applied by deconstructing the postoperative CBCT model into the Model and Model and replacing it with bone from preoperative CBCT and standard implant models, respectively. In vivo, 52 implants were included, and the VF of each implant was obtained using data processing methods similar to those used ex vivo. Then, we compared the results of CM and VF.
Ex vivo, the VF was similar to GS, while CM usually underestimated the peri-implant bone thickness, especially at the implant shoulder (P < 0.01). In vivo, on CBCT, areas with a peri-implant bone thickness of 0-0.50 mm were not visible, while those with a thickness of 0.50-1.00 mm were occasionally visible. There was less underestimation of bone along the implant long axis.
Thin peri-implant bones could be completely underestimated on CBCT. CBCT scans alone are insufficient to warrant surgical intervention. Our NVM facilitates the accurate visual assessment of implant dimensions.
The thickness of peri-implant bone could be completely underestimated when thinner than 1.0 mm in living patients. Familiarity with these confusing CBCT results may help clinicians and patients avoid further unnecessary evaluation, misdiagnosis, and invasive treatment.
本研究旨在通过一种新的可视化方法(NVM)研究活体患者中锥形束 CT(CBCT)测量种植体周围骨厚度的准确性。
通过使用牛肋骨的原始术后 CBCT(临床测量,CM)、使用 NVM 获得的可视化融合图像(可视化融合测量,VF)和硬组织切片(金标准测量,GS)来验证 NVM 的有效性。NVM 是通过将术后 CBCT 模型分解为模型和模型,并分别用术前 CBCT 和标准植入模型中的骨进行替换来应用的。在体内,共纳入 52 个种植体,使用类似于体外使用的数据处理方法获得每个种植体的 VF。然后,我们比较了 CM 和 VF 的结果。
在体外,VF 与 GS 相似,而 CM 通常低估了种植体周围骨的厚度,尤其是在种植体肩部(P < 0.01)。在体内,CBCT 上,0-0.50 毫米厚的种植体周围骨区域不可见,而 0.50-1.00 毫米厚的区域偶尔可见。沿种植体长轴低估的骨较少。
在 CBCT 上,薄的种植体周围骨可能会被完全低估。单独的 CBCT 扫描不足以保证手术干预。我们的 NVM 便于对植入物尺寸进行准确的视觉评估。
在活体患者中,当种植体周围骨厚度小于 1.0 毫米时,可能会完全低估。熟悉这些令人困惑的 CBCT 结果可能有助于临床医生和患者避免进一步不必要的评估、误诊和侵入性治疗。